当前位置: 首页 >> 检索结果
共有 3981 条符合本次的查询结果, 用时 5.727938 秒

3921. Associations of Serum Adipokines With Subclinical Interstitial Lung Disease Among Community-Dwelling Adults: The Multi-Ethnic Study of Atherosclerosis (MESA).

作者: John S Kim.;Michaela R Anderson.;Anna J Podolanczuk.;Steven M Kawut.;Matthew A Allison.;Ganesh Raghu.;Karen Hinckley-Stuckovsky.;Eric A Hoffman.;Russell P Tracy.;R Graham Barr.;David J Lederer.;Jon T Giles.
来源: Chest. 2020年157卷3期580-589页
Adipokines have inflammatory and fibrotic properties that may be critical in interstitial lung disease (ILD). We examined associations of serum adipokine levels with CT imaging-based measures of subclinical ILD and lung function among community-dwelling adults.

3922. Mobile Health Technologies in Cardiopulmonary Disease.

作者: Grant E MacKinnon.;Evan L Brittain.
来源: Chest. 2020年157卷3期654-664页
Mobile health (mHealth) technologies are modernizing medicine by affording greater patient engagement, monitoring, outreach, and health-care delivery. The cardiopulmonary fields have led the integration of mHealth into clinical practice and research. mHealth technologies in these areas include smartphone applications, wearable devices, and handheld devices, among others, and provide real-time monitoring of numerous important physiological measurements and other key parameters. Use of mHealth-compatible devices has increased in recent years, and age and socioeconomic gaps of ownership are narrowing. These tools provide physicians and researchers with a better understanding of an individual's health and well-being. mHealth interventions have shown utility in the prevention, monitoring, and management of atrial fibrillation, heart failure, and myocardial infarction. With the growing prevalence of cardiopulmonary disease, mHealth technologies may become a more essential element of care within and outside of traditional health-care settings. mHealth is continuously developing as a result of technologic advancements and better understandings of mHealth utility. However, there is little regulation on the mHealth platforms available for commercial use and even fewer guidelines on implementing evidence-based practices into mHealth technologies. Online security is another challenge and necessitates development in data collection infrastructure to manage the extraordinary volume of patient data. Continued research on long-term implications of mHealth technology and the integration of effective interventions into clinical practice is required.

3923. Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.

作者: Nathan Schoettler.;Mary E Strek.
来源: Chest. 2020年157卷3期516-528页
This review focuses on recent clinical and translational discoveries in severe and uncontrolled asthma that now enable phenotyping and personalized therapies in these patients. Although asthma is common in both children and adults and typically responds to standard therapies, a subset of individuals with asthma experience severe and/or persistent symptoms despite appropriate therapies. Airflow obstruction leading to frequent symptoms requiring higher levels of controller therapy is the cardinal feature of severe asthma, but the underlying molecular mechanisms, or endotypes, are diverse and variable between individuals. Two major risk factors that contribute to severe asthma are genetics and environmental exposures that modulate immune responses, and although these often interact in complex manners that are not fully understood, certain endotypes converge in severe asthma. A number of studies have evaluated various features of patients with severe asthma and classified patients into phenotypes with clinical relevance. This phenotyping is now incorporated into clinical practice and can be used to guide advanced biological therapies that target specific molecules and inflammatory pathways that contribute to asthma pathogenesis.

3924. Rate and Predictors of Bacteremia in Afebrile Community-Acquired Pneumonia.

作者: Christina Forstner.;Vladimir Patchev.;Gernot Rohde.;Jan Rupp.;Martin Witzenrath.;Tobias Welte.;Heinz Burgmann.;Mathias W Pletz.; .
来源: Chest. 2020年157卷3期529-539页
Although blood cultures (BCs) are the "gold standard" for detecting bacteremia, the utility of BCs in patients with community-acquired pneumonia (CAP) is controversial. This study describes the proportion of patients with CAP and afebrile bacteremia and identifies the clinical characteristics predicting the necessity for BCs in patients who are afebrile.

3925. Lung Involvement in Destombes-Rosai-Dorfman Disease: Clinical and Radiological Features and Response to the MEK Inhibitor Cobimetinib.

作者: Quentin Moyon.;Samia Boussouar.;Philippe Maksud.;Jean-François Emile.;Frédéric Charlotte.;Nathalie Aladjidi.;Grégoire Prévot.;Jean Donadieu.;Zahir Amoura.;Philippe Grenier.;Julien Haroche.;Fleur Cohen Aubart.
来源: Chest. 2020年157卷2期323-333页
Destombes-Rosai-Dorfman disease (RDD) is a rare multisystemic histiocytosis. Pulmonary involvement during RDD has been poorly described. The goal of this study was to examine the clinical presentations, radiological features, and outcomes of 15 patients with RDD and lung involvement.

3926. Early-Life Exposure to Oral Antibiotics and Lung Function Into Early Adulthood.

作者: Karoliny Dos Santos.;Caroline J Lodge.;Michael J Abramson.;Bircan Erbas.;Catherine M Bennett.;Jennie Hui.;Shyamali C Dharmage.;Adrian J Lowe.
来源: Chest. 2020年157卷2期334-341页
Although there is ongoing debate regarding the impact of early postnatal exposure to antibiotics on the development of asthma, the possibility that antibiotic exposure may impair lung function has not previously been examined. Furthermore, it is unclear if specific types of antibiotics may have a greater effect, or if children with genetic mutations in the oxidative stress response glutathione S-transferase (GST) superfamily may be at greater risk.

3927. Association of Contrast and Acute Kidney Injury in the Critically Ill: A Propensity-Matched Study.

作者: Lisa-Mae S Williams.;Gail R Walker.;James W Loewenherz.;Louis T Gidel.
来源: Chest. 2020年157卷4期866-876页
Despite evidence that low osmolar radiocontrast media is not associated with acute kidney injury, it is important to evaluate this association in critically ill patients with normal kidney function.

3928. Better With Ultrasound: Peripheral Intravenous Catheter Insertion.

作者: Scott J Millington.;Ariel Hendin.;Ariel L Shiloh.;Seth Koenig.
来源: Chest. 2020年157卷2期369-375页
Peripheral intravenous (PIV) catheter insertion is the most commonly performed procedure in hospitals. Multiple patient factors can make PIV insertion challenging, and ultrasound guidance has been demonstrated to improve the rate of success in these difficult patients. This article outlines the suggested techniques for the ultrasound-guided insertion of PIV catheters, midline catheters, and peripherally inserted central catheters. Illustrative figures and narrative videos demonstrating these techniques are included.

3929. Redesigning Care for OSA.

作者: Lucas M Donovan.;Aditi Shah.;Ching Li Chai-Coetzer.;Ferran Barbé.;Najib T Ayas.;Vishesh K Kapur.
来源: Chest. 2020年157卷4期966-976页
Constrained by a limited supply of specialized personnel, health systems face a challenge in caring for the large number of patients with OSA. The complexity of this challenge is heightened by the varied clinical presentations of OSA and the diversity of treatment approaches. Innovations such as simplified home-based care models and the incorporation of nonspecialist providers have shown promise in the management of uncomplicated patients, producing comparable outcomes to the resource-intensive traditional approach. However, it is unclear if these innovations can meet the needs of all patients with OSA, including those with mild disease, atypical presentations, and certain comorbid medical and mental health conditions. This review discusses the diversity of needs in OSA care, the evidence base behind recent care innovations, and the potential limitations of each innovation in meeting the diversity of care needs. We propose how these innovations can fit within the stepped care and hub and spoke models in a way that addresses the full spectrum of OSA, and we discuss future research directions to assess the deployment of these innovations.

3930. Better With Ultrasound: Arterial Line Placement.

作者: Ann Wang.;Ariel Hendin.;Scott J Millington.;Seth Koenig.;Lewis A Eisen.;Ariel L Shiloh.
来源: Chest. 2020年157卷3期574-579页
Arterial catheterization is frequently performed in ICUs to facilitate hemodynamic monitoring and frequent blood sampling. Overall, arterial catheterization has high success and low complication rates, but in patients who are critically ill, the incidence of failure is higher because of hypotension, peripheral edema, and obesity. Ultrasound guidance significantly increases the likelihood of successful cannulation and decreases complications compared with traditional landmark-based techniques. Multiple ultrasound techniques for radial and femoral arterial catheter insertion have been described; this paper presents an approach for incorporating these tools into bedside practice, including illustrative figures and narrated video presentations to demonstrate the techniques described.

3931. Adequacy of the Provider Workforce for Persons With Cardiopulmonary Disease.

作者: Robert L Joyner.;Shawna L Strickland.;Ellen A Becker.;Emily Ginier.;Shane Keene.;Kathy Rye.;Carl F Haas.
来源: Chest. 2020年157卷5期1221-1229页
Access and quality of health care for cardiopulmonary disease in the United States ranks poorly compared with economically similar nations. No recent comprehensive assessment of the cardiopulmonary workforce is available. This systematic review was conducted to evaluate current published evidence about the workforce caring for persons with cardiopulmonary disease.

3932. Association Between Volume of Fluid Resuscitation and Intubation in High-Risk Patients With Sepsis, Heart Failure, End-Stage Renal Disease, and Cirrhosis.

作者: Rizwan A Khan.;Nauman A Khan.;Seth R Bauer.;Manshi Li.;Abhijit Duggal.;Xiaofeng Wang.;Anita J Reddy.
来源: Chest. 2020年157卷2期286-292页
Initial fluid resuscitation volume for sepsis is controversial, particularly in patients at high baseline risk for complications. This study was designed to assess the association between 30 mL/kg crystalloids and intubation in patients with sepsis or septic shock and heart failure, end-stage renal disease, or cirrhosis.

3933. Plasma Mitochondrial DNA Levels Are Associated With ARDS in Trauma and Sepsis Patients.

作者: Hilary E Faust.;John P Reilly.;Brian J Anderson.;Caroline A G Ittner.;Caitlyn M Forker.;Peggy Zhang.;Benjamin A Weaver.;Daniel N Holena.;Paul N Lanken.;Jason D Christie.;Nuala J Meyer.;Nilam S Mangalmurti.;Michael G S Shashaty.
来源: Chest. 2020年157卷1期67-76页
Critically ill patients who develop ARDS have substantial associated morbidity and mortality. Circulating mitochondrial DNA (mtDNA) released during critical illness causes endothelial dysfunction and lung injury in experimental models. This study hypothesized that elevated plasma mtDNA is associated with ARDS in critically ill patients with trauma and sepsis.

3934. Sleep Pharmacotherapy for Common Sleep Disorders in Pregnancy and Lactation.

作者: Margaret A Miller.;Niharika Mehta.;Courtney Clark-Bilodeau.;Ghada Bourjeily.
来源: Chest. 2020年157卷1期184-197页
Sleep disturbances are common in pregnancy, and sleep disorders may worsen or present de novo in the course of gestation. Managing a pregnant patient is complicated by the risk of teratogenicity, pharmacokinetic changes, and the dynamic nature of pregnancy. Although nonpharmacologic interventions are likely safest, they are often ineffective, and a patient is left dealing with frustrations of the sleep disturbance, as well as the negative outcomes of poor sleep in pregnancy. As with any other condition in pregnancy, management requires an understanding of pregnancy physiology, knowledge of the impact of a given condition on pregnancy or fetal and neonatal outcomes, and an ability to weigh the risk of the exposure to an untreated, or poorly treated condition, against the risk of a given drug. In partnership with the pregnant patient or couple, options for therapy should be reviewed in the context of the impact of the condition on pregnancy and offspring outcomes, while understanding that data (positive or negative) on the impact of therapy on perinatal outcomes are lacking. This article reviews the epidemiology of sleep disorders in pregnancy, general principles of prescribing in pregnancy and lactation, and safety surrounding therapeutic options in pregnancy.

3935. Corticosteroid Withdrawal-Induced Loss of Control in Mild to Moderate Asthma Is Independent of Classic Granulocyte Activation.

作者: Linsey E S de Groot.;Marianne A van de Pol.;Niki Fens.;Barbara S Dierdorp.;Tamara Dekker.;Wim Kulik.;Christof J Majoor.;Jörg Hamann.;Peter J Sterk.;René Lutter.
来源: Chest. 2020年157卷1期16-25页
Loss of asthma control and asthma exacerbations are associated with increased sputum eosinophil counts. However, whether eosinophils, or the also present neutrophils, actively contribute to the accompanying inflammation has not been extensively investigated.

3936. Pleural Cryobiopsy: A Systematic Review and Meta-Analysis.

作者: Majid Shafiq.;Jaskaran Sethi.;Muhammad S Ali.;Uzair K Ghori.;Tajalli Saghaie.;Erik Folch.
来源: Chest. 2020年157卷1期223-230页
Pleural biopsy using either video-assisted thoracoscopic surgery or medical pleuroscopy is the current diagnostic criterion standard for pleural pathology with a high, yet imperfect, diagnostic yield. Cryobiopsy may provide greater tissue, increase depth of sampled tissue, and/or reduce crush artifact. However, its impact on diagnostic yield remains uncertain, and there are potential concerns regarding its safety too. We performed a systematic review and meta-analysis to investigate the same.

3937. A Blueprint for Success: Design and Implementation of an Ideal Bronchoscopy Suite.

作者: Atul C Mehta.;Sameer K Avasarala.;Prasoon Jain.;Himanshu Deshwal.;Thomas R Gildea.
来源: Chest. 2020年157卷3期712-723页
Bronchoscopy is essential to the practice of pulmonary medicine. It is an important diagnostic and therapeutic tool for many disease processes. Bronchoscopy can be performed in a variety of clinical settings, from the bedside to an operating room. Although bronchoscopy has been practiced for more than a century, consensus recommendations from stakeholders have yet to be developed for the planning, implementation, and construction of a bronchoscopy suite. A wide range of procedures can be performed via bronchoscopy; therefore, the required tools and the procedure area must be aligned with the needs of the facility. Designing a bronchoscopy suite is by no means a "one size fits all" process. We present an overview of critical features to be considered in the planning for an ideal bronchoscopy suite. We use the term "ideal" because it represents a subjective conception of what is perfect and does not convey a rigid, universal blueprint.

3938. Quality Gaps and Comparative Effectiveness in Lung Cancer Staging and Diagnosis.

作者: David E Ost.;Jiangong Niu.;Hui Zhao.;Horiana B Grosu.;Sharon H Giordano.
来源: Chest. 2020年157卷5期1322-1345页
Guidelines recommend mediastinal sampling first for patients with mediastinal lymphadenopathy with suspected lung cancer. The objective of this study was to describe practice patterns and outcomes of diagnostic strategies in patients with lung cancer.

3939. Incidence and Mortality of Adults Hospitalized With Community-Acquired Pneumonia According to Clinical Course.

作者: Paula Peyrani.;Forest W Arnold.;Jose Bordon.;Stephen Furmanek.;Carlos M Luna.;Rodrigo Cavallazzi.;Julio Ramirez.
来源: Chest. 2020年157卷1期34-41页
After hospitalization for community-acquired pneumonia (CAP), patients' clinical course may progress to clinical improvement, clinical failure, or nonresolving pneumonia. The epidemiology and outcomes of patients with CAP according to clinical course has not been well studied. The objective of this study was to characterize the incidence and outcomes for each clinical course of hospitalized patients with CAP.

3940. Usefulness of Simplified Pulmonary Embolism Severity Index Score for Identification of Patients With Low-Risk Pulmonary Embolism and Active Cancer: From the COMMAND VTE Registry.

作者: Yugo Yamashita.;Takeshi Morimoto.;Hidewo Amano.;Toru Takase.;Seiichi Hiramori.;Kitae Kim.;Maki Oi.;Masaharu Akao.;Yohei Kobayashi.;Mamoru Toyofuku.;Toshiaki Izumi.;Tomohisa Tada.;Po-Min Chen.;Koichiro Murata.;Yoshiaki Tsuyuki.;Yuji Nishimoto.;Syunsuke Saga.;Tomoki Sasa.;Jiro Sakamoto.;Minako Kinoshita.;Kiyonori Togi.;Hiroshi Mabuchi.;Kensuke Takabayashi.;Yusuke Yoshikawa.;Hiroki Shiomi.;Takao Kato.;Takeru Makiyama.;Koh Ono.;Takeshi Kimura.; .
来源: Chest. 2020年157卷3期636-644页
The simplified Pulmonary Embolism Severity Index (sPESI) score is a practical score for identification of patients with low-risk pulmonary embolism (PE), although it has not been applied in patients with active cancer. The current study aimed to evaluate the usefulness of the sPESI score in patients with PE and active cancer.
共有 3981 条符合本次的查询结果, 用时 5.727938 秒